Relationship between the prevalence of cardiometabolic diseases and the presence of psoriatic arthritis in Russian patients with psoriasis
Abstract
Psoriasis is associated with an increased risk of cardiometabolic pathology. Comparative studies of this pathology’s prevalence in patients with psoriasis depending on the presence of psoriatic arthritis (PsA) in a representative sample of Russian patients have not been conducted.
Objective:to compare the prevalence of cardiometabolic diseases in Russian patients with psoriasis depending on the presence or absence of PsA.
Material and methods. The data of the register of patients with psoriasis of the Russian Society of dermatovenerologists and Cosmetologists (RODVK) were analyzed. Inclusion criteria: age >18 years, information about the established diagnosis of PsA. A comparison was made between patients with PsA and two comparison groups: all patients without PsA and patients without PsA with a duration of psoriasis exceeding the established value.
Results and discussion. The analysis included 920 patients with PsA (group 1) and 2325 patients with psoriasis without PsA (group 2). Group 3 included 655 patients from group 2.
The prevalence of cardiometabolic diseases in patients with PsA was higher than in group 2. When compared to group 3, the statistically significant differences were noted only for impaired glucose tolerance. However, adjusted for gender and age, patients with PsA had statistically significant higher chances of developing arterial hypertension (AH), coronary heart disease, angina pectoris, acute cerebrovascular accident, impaired glucose tolerance and diabetes mellitus than patients in group 3. When adjusting for disease risk factors, the statistical significance of differences remained for hypertension and angina pectoris.
Conclusion. The prevalence of cardiometabolic diseases in Russian patients with PsA is higher than in patients with psoriasis without PsA.
About the Authors
E. V. Bogdanova
State Scientific Center for Dermatovenereology and Cosmetology, Ministry of Health of Russia
Russian Federation
Russian Federation
Elena Vitalievna Bogdanova
3, Korolenko Street, Build. 6, Moscow 107076
A. A. Kubanov
State Scientific Center for Dermatovenereology and Cosmetology, Ministry of Health of Russia
Russian Federation
Russian Federation
3, Korolenko Street, Build. 6, Moscow 107076
References
1. Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017 Mar;76(3): 377-90. doi: 10.1016/j.jaad.2016.07.064
2. Karmacharya P, Ogdie A, Eder L. Psoriatic arthritis and the association with cardiometabolic disease: a narrative review. Ther Adv Musculoskelet Dis. 2021 Mar 2;13: 1759720X21998279. doi: 10.1177/1759720X21998279
3. Bengtsson K, Forsblad-d'Elia H, Lie E, et al. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075017-1315-z
4. Lauper K, Courvoisier DS, Chevallier P, et al. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2018 Dec;70(12):1756-63. doi: 10.1002/acr.23567
5. Kubanov AA, Bogdanova EV. Epidemiology of psoriasis in the Russian Federation according to the patient registry. Vestnik dermatologii i venerologii. 2022;98(1):33-41. (In Russ.).
6. Bogdanova EV. The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis. Vestnik dermatologii i venerologii. 2022; 98(4):41-8. (In Russ.).
7. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013 Mar; 31(3):433-42. doi: 10.1097/HJH.0b013e32835bcce1
8. Duan X, Liu J, Mu Y, et al. A systematic review and meta-analysis of the association bet ween psoriasis and hypertension with adjustment for covariates. Medicine (Baltimore). 2020 Feb;99(9):e19303. doi: 10.1097/MD.0000000000019303
9. Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and metaanalysis of observational studies. J Am Heart Assoc. 2013 Apr 4;2(2):e000062. doi: 10.1161/JAHA.113.000062
10. Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675
11. Ogdie A, Haynes K, Troxel AB, et al. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis. 2014 Jan; 73(1):149-53. doi: 10.1136/annrheumdis2012-202424
12. Dhana A, Yen H, Yen H, Cho E. All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis. J Am Acad Dermatol. 2019 May;80(5):1332-43. doi: 10.1016/j.jaad.2018.12.037
13. Ogdie A, Maliha S, Shin D, et al. Causespecific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017 Jun 1;56(6):907-11. doi: 10.1093/rheumatology/kew502
14. Karmacharya P, Chakradhar R, Ogdie A. The epidemiology of psoriatic arthritis: A literature review. Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101692. doi: 10.1016/j.berh.2021.101692
15. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr;68(4):654-62. doi: 10.1016/j.jaad.2012.08.015
16. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and metaanalysis of observational studies. Nutr Diabetes. 2012 Dec 3;2(12):e54. doi: 10.1038/nutd.2012.26
17. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013 Jan;149(1):84-91. doi: 10.1001/2013.jamadermatol.406
18. Coto-Segura P, Eiris-Salvado N, Gonzalez-Lara L, et al. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol. 2013 Oct;169(4):783-93. doi: 10.1111/bjd.12473
19. Yuan Z, Guo Y. Risk of incident type 2 diabetes in patients with psoriatic arthritis: A systematic review and meta-analysis of cohort studies. Int J Rheum Dis. 2022 Sep; 25(9):1029-37. doi: 10.1111/1756-185X.14375
20. Loganathan A, Kamalaraj N, El-Haddad C, Pile K. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis. 2021 Sep;24(9): 1112-20. doi: 10.1111/1756-185X.14147
21. Perez-Plaza A, Carretero G, Ferrandiz C, et al. Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-8. doi: 10.1111/jdv.14188
22. Kavanaugh A, Papp K, Gottlieb AB, et al. Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry. BMC Rheumatol. 2018 Sep 29;2:29. doi: 10.1186/s41927-0180034-7
23. Korsakova YuL, Korotaeva TV, Loginova EYu, et al. The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register. Terapevticheskii Arkhiv. 2021; 93(5):573-80. (In Russ.).
24. Loginova EYu, Korotaeva TV, Korsakova YuL, et al. The clinical status and working capacity in patients included in the All-Russian Psoriatic Arthritis Registry. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2020; 14(3):19-26. (In Russ.). doi: 10.14412/19967012-2020-3-19-26
25. Korsakova YL, Korotaeva TV, Loginova EI, et al. The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register. Nauchcno-Prakticheskaya Revmatologia. 2021;59(3):275-81 (In Russ.).
26. Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken). 2011 Dec;63(12):1729-35. doi: 10.1002/acr.20627
27. Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019 Mar;15(3): 153-66. doi: 10.1038/s41584-019-0175-0
28. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013 May;72(5):736-40. doi: 10.1136/annrheumdis-2012-201706
29. Karmacharya P, Wright K, Achenbach SJ, et al. Diagnostic Delay in Psoriatic Arthritis: A Population-based Study. J Rheumatol. 2021; 48(9):1410-16. doi: 10.3899/jrheum.201199
30. Guillen Astete CA, Gaite Gonzalez I, Zurita Prada PA, Urrego Laurin C. Delay and Diagnostic Pathway of Patients with Psoriatic Arthritis in Spain. Reumatol Clin (Engl Ed). 2020 Jul 6;S1699-258X(20)30137-6. doi: 10.1016/j.reuma.2020.05.009. Online ahead of print.
31. Kubanov AA, Bogdanova EV. Periods till Psoriatic Arthritis Onset and Diagnosis in Russian Patients with Moderate to Severe Psoriasis. Vestnik dermatologii i venerologii. 2023;99(1):48-54. (In Russ.).
32. Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017 Dec 1; 56(12):2109-13. doi: 10.1093/rheumatology/kex323.
33. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. N Engl J Med. 2017 Mar 9;376(10):957-70. doi: 10.1056/NEJMra1505557.
34. Haddad A, Zisman D. Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J. 2017 Jan 30;8(1):e0004. doi: 10.5041/RMMJ.10279
35. Kubanov AA, Bogdanova EV. What Are Patient Registries And Why Are They Needed (Through a Number of Examples of Psoriasis Registries). Vestnik RAMN. 2021;76(2): 177-86. (In Russ.).
Review
For citations:
Bogdanova EV, Kubanov AA. Relationship between the prevalence of cardiometabolic diseases and the presence of psoriatic arthritis in Russian patients with psoriasis. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2023;17(2):37-43. (In Russ.)
Views:
397
Email this article 